(Eli Lilly, which makes another GLP-1 drug, tirzepatide, was also included in the lawsuit.) The new research, based on health insurance claims from 2006 to 2020 from more than 5,000 patients in the U.S., looked at how many people developed one of four serious gastrointestinal problems biliary disease, gastroparesis, pancreatitis or bowel obstructions after they were prescribed one of the weight loss drugs
Those bacteria ferment the food, and that fermentation produces gas, including methane, hydrogen, carbon dioxide, and hydrogen sulfide
A nutrition-focused approach paired with semaglutide therapy prevents the metabolism slowdown that derails many dieters
Tolerability, dose escalation, and treatment progress are reviewed regularly by a physician